I am a fan of PTX - if a biotech will be successful this one will. Yale provenance, Paul Hopper(who has had his fair share of fails too) and finding itself in the hot area of novel immunotherapy.
These results say PTX200 perhaps is effective. But as we all know, a blockbuster is not just an incremental improvement on standard of care. Are we there yet?
This is the fun of investing in this sector - if you are after growth not trading, science is your friend. Then again you can make $ whilst the turtle finally catches up to the rabbit.
GLTAH
- Forums
- ASX - By Stock
- PTX
- Ann: PTX-200 High Overall Response in Ph2a Breast Cancer trial
Ann: PTX-200 High Overall Response in Ph2a Breast Cancer trial, page-44
-
-
- There are more pages in this discussion • 302 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PTX (ASX) to my watchlist
|
|||||
Last
4.7¢ |
Change
-0.002(4.08%) |
Mkt cap ! $37.85M |
Open | High | Low | Value | Volume |
4.9¢ | 5.0¢ | 4.6¢ | $54.50K | 1.134M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 108715 | 4.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.9¢ | 189091 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 108715 | 0.047 |
4 | 299374 | 0.046 |
3 | 220000 | 0.045 |
1 | 400000 | 0.044 |
6 | 484598 | 0.043 |
Price($) | Vol. | No. |
---|---|---|
0.049 | 189091 | 2 |
0.050 | 348310 | 3 |
0.052 | 19230 | 1 |
0.054 | 51093 | 1 |
0.055 | 325000 | 3 |
Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
Featured News
PTX (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online